Lung Cancer – Page 3 – PossibleThreat Articles

New insights into the structure and function of Cdc34, a target for cancer therapeutics

October 17, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Leukemia, Lung Cancer, Lymphoma, Pancreatic Cancer

Researchers report they have obtained 3D structural snapshots of Cdc34 in action. Cdc34 is an enzyme important for cell cycle regulation and a target for therapeutic intervention in cancer. These structures, along with studies in human cells, have revealed key features of this enzyme important for its regulation of cell growth and activity. These unique features could present opportunities for rational design of novel cancer therapeutics.

News Science

Exercise guidelines for cancer survivors

October 17, 2019 0 Comments Breast Cancer, Cancer, Colon Cancer, Diseases and Conditions, Fitness, Lung Cancer, Men's Health, Ovarian Cancer

For the rising number of cancer survivors worldwide, there's growing evidence that exercise is an important part of recovery. But how much, and what type of exercise, is needed?

News Science

Smoke signals: Study shows path linking nicotine addiction to increased risk for diabetes

October 17, 2019 0 Comments Brain Tumor, Diabetes, Diseases and Conditions, Hormone Disorders, Hypertension, Lung Cancer, Personalized Medicine, Smoking

Researchers have discovered a circuit in rats that links cigarette smoking and the risk of developing type 2 diabetes, according to a new study.

News Science

Beyond Mutation: Cause of drug resistance in a type of intestinal tumors

October 17, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Genes, Lung Cancer, Personalized Medicine, Prostate Cancer

Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.

News Science

Pioneering cell therapies for non-responders to current immunotherapies

October 16, 2019 0 Comments Brain Tumor, Cancer, Colon Cancer, Diseases and Conditions, Immune System, Lung Cancer, Lymphoma, Skin Cancer

New research signposts a new, less invasive approach to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to approved immune-based treatments.

News Science

New marker for tumor aggression in neurofibromatosis type 1

October 16, 2019 0 Comments Bladder Cancer, Brain Tumor, Cancer, Diseases and Conditions, Lung Cancer, Ovarian Cancer, Prostate Cancer, Skin Cancer

A new study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggressive in those with NF1. According to the researchers, the clues could advance the search for more customized and relevant treatments that spare patients exposure to treatments unlikely to work.

News Science

Progress in global cancer fight is not only possible, but achievable

October 16, 2019 0 Comments Brain Tumor, Breast Cancer, Cancer, Colon Cancer, Leukemia, Lung Cancer, Ovarian Cancer, Pancreatic Cancer

The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

News Science

Glowing particles in the blood may help diagnose and monitor brain cancer

October 16, 2019 0 Comments Brain Injury, Brain Tumor, Brain-Computer Interfaces, Cancer, Intelligence, Lung Cancer, neuroscience, Ovarian Cancer

A chemical that has improved surgeries for brain cancer by making tumor cells fluorescent may also help doctors safely diagnose the disease and monitor its response to treatment.

News Science

Drug-light combo could offer control over CAR T-cell therapy

October 16, 2019 0 Comments Brain Tumor, Cancer, Immune System, Lung Cancer, Lymphoma, Prostate Cancer, Skin Cancer, Stem Cells

Bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells. The system requires two 'keys' — the drug Tamoxifen and blue light — to activate CAR T cells to bind to their targets.

News Science

Inactive receptor renders cancer immunotherapies ineffective

October 16, 2019 0 Comments Breast Cancer, Cancer, Colon Cancer, Diseases and Conditions, Immune System, Lung Cancer, Lymphoma, Skin Cancer

The aim of immunotherapies is to enable the immune system once again to fight cancer on its own. Drugs known as checkpoint inhibitors are already in clinical use for this purpose. However, they are only effective in about one third of patients. Based on analysis of human tissue samples, a team has now discovered one reason why this is so: an inactive receptor in cancer cells prevents the drugs from reactivating the immune system.